Condition: Head and Neck Neoplasms
Interventions: Biological: Durvalumab; Biological: Cetuximab; Radiation: Intensity modulated radiation therapy (IMRT)
Sponsor: Azienda Ospedaliero-Universitaria Careggi
Not yet recruiting - verified February 2017
http://ift.tt/2kt1IYV
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: June 2018 Source: Acta Biomaterialia, Volume 73 https://ift.tt/2kBbISt
-
http://bit.ly/2SylJiJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου